Cprd

Pimenta, J. M., Irving, M., Cheung, M., Mazzeo, L., Landis, S., & Mukherjee, S. (2023). Higher rates of non-skeletal complications and greater healthcare needs in achondroplasia compared to the general UK population: a matched cohort study using the CPRD database. Orphanet J Rare Dis, 18, 211. http://doi.org/10.1186/s13023-023-02811-5
Minassian, C., Allen, L. A., Okosieme, O., Vaidya, B., & Taylor, P. (2023). Preconception management of hyperthyroidism and thyroid status in subsequent pregnancy: a population-based cohort study. J Clin Endocrinol Metab. http://doi.org/10.1210/clinem/dgad276
Simon, V., & Vadel, J. (2023). Evaluating the Performance of High-Dimensional Propensity Scores Compared with Standard Propensity Scores for Comparing Antihypertensive Therapies in the CPRD GOLD Database. Cardiol Ther, 12, 393-408. http://doi.org/10.1007/s40119-023-00316-7
Virdee, P. S., Bankhead, C., Koshiaris, C., Drakesmith, C. W., Oke, J., Withrow, D., et al. (2023). BLOod Test Trend for cancEr Detection (BLOTTED): protocol for an observational and prediction model development study using English primary care electronic health record data. Diagn Progn Res, 7, 1. http://doi.org/10.1186/s41512-022-00138-6
Khachatryan, A., Doobaree, I. U., Spentzouris, G., Gusto, G., Zawaneh, Y., Mughal, F., et al. (2022). Direct Oral Anticoagulant (DOAC) Dosing in Patients with Non-valvular Atrial Fibrillation (NVAF) in the United Kingdom: A Retrospective Cohort Study Using CPRD Gold Database. Adv Ther. http://doi.org/10.1007/s12325-022-02368-y
Domzaridou, E., Carr, M. J., Webb, R. T., Millar, T., & Ashcroft, D. M. (2022). Non-fatal overdose risk during and after opioid agonist treatment: A primary care cohort study with linked hospitalisation and mortality records. Lancet Reg Health Eur, 22, 100489. http://doi.org/10.1016/j.lanepe.2022.100489
Tianyi, F. L., Li, Y., Alderdice, F., Quigley, M. A., Kurinczuk, J. J., Bankhead, C., & Carson, C. (2022). The association between conception history and subsequent postpartum depression and/or anxiety: Evidence from the Clinical Practice Research Datalink 1991-2013. J Affect Disord, 310, 266-273. http://doi.org/10.1016/j.jad.2022.04.138
Elwenspoek, M. M. C., O'Donnell, R., Jackson, J., Everitt, H., Gillett, P., Hay, A. D., et al. (2022). Development and external validation of a clinical prediction model to aid coeliac disease diagnosis in primary care: An observational study. Eclinicalmedicine, 46, 101376. http://doi.org/10.1016/j.eclinm.2022.101376
van Veelen, A., Abtahi, S., Souverein, P., Driessen, J. H. M., Klungel, O. H., Dingemans, A. C., et al. (2022). Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inhibitors. Cancer Epidemiol, 78, 102149. http://doi.org/10.1016/j.canep.2022.102149
Mueller, A. M., Meier, C. R., Jick, S. S., & Schneider, C. (2022). Characterization of the deterioration of diabetes control in patients with a subsequent diagnosis of pancreatic cancer: A descriptive study. Pancreatology. http://doi.org/10.1016/j.pan.2022.03.012